{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:32:13Z","timestamp":1777501933384,"version":"3.51.4"},"reference-count":126,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cardfail.2023.03.028","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T03:33:48Z","timestamp":1681702428000},"page":"1078-1090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992\u20132004)"],"prefix":"10.1016","volume":"29","author":[{"given":"MILTON","family":"PACKER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2023.03.028_bib0001","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI103834","article-title":"Cardiac, hemodynamic and renal functions in congestive heart failure during induced peripheral vasodilatation; relationship to Starling's law of the heart in man","volume":"38","author":"Sobol","year":"1959","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0002","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.CIR.13.5.664","article-title":"The effects of intravenous apresoline (hydralazine) on cardiovascular and renal function in patients with and without congestive heart failure","volume":"13","author":"Hollander","year":"1956","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0003","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-50-1-34","article-title":"Effects of sublingual nitroglycerin on pulmonary arterial pressure in patients with left ventricular failure","volume":"50","author":"Johnson","year":"1959","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0004","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1172\/JCI105788","article-title":"A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure","volume":"47","author":"Zelis","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0005","first-page":"978","article-title":"Phentolamine for vasodilator treatment of severe heart-failure","volume":"2","author":"Perret","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.48.1.5","article-title":"Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance","volume":"48","author":"Cohn","year":"1973","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM197409192911201","article-title":"Treatment of refractory heart failure with infusion of nitroprusside","volume":"291","author":"Guiha","year":"1974","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1378\/chest.73.1.8","article-title":"Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside","volume":"73","author":"Pierpont","year":"1978","journal-title":"Chest"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0009","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9149(77)90199-0","article-title":"Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure","volume":"40","author":"Massie","year":"1977","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0010","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/0002-9149(78)90642-2","article-title":"Oral vasodilator therapy for chronic heart failure. A plea for caution","volume":"42","author":"Packer","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0011","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.CIR.59.3.531","article-title":"Clinical and hemodynamic tachyphylaxis to prazosin mediated afterload reduction in severe congestive heart failure","volume":"59","author":"Packer","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0012","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0735-1097(84)80364-2","article-title":"Relationship between serum sodium concentration and the hemodynamic and clinical responses to converting-enzyme inhibition with captopril in severe heart failure","volume":"3","author":"Packer","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0013","doi-asserted-by":"crossref","first-page":"782","DOI":"10.7326\/0003-4819-100-6-782","article-title":"Correction of dilutional hyponatremia in patients with severe chronic heart failure by converting-enzyme inhibition","volume":"100","author":"Packer","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0014","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/01.CIR.70.6.1038","article-title":"Hemodynamic and clinical limitations of long term inotropic therapy with amrinone in patients with severe chronic heart failure","volume":"70","author":"Packer","year":"1984","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.71.4.761","article-title":"Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure","volume":"71","author":"Packer","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0016","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0735-1097(89)90344-6","article-title":"Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure","volume":"13","author":"Gottlieb","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0017","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/01.CIR.81.3.860","article-title":"Comparative hemodynamic effects of procainamide, tocainide and encainide in chronic heart failure","volume":"81","author":"Gottlieb","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0018","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJM197911293012201","article-title":"Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure","volume":"301","author":"Packer","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0019","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/01.CIR.64.3.506","article-title":"Determinants of drug response in severe chronic heart failure. I. Activation of vasoconstrictor forces during vasodilator therapy","volume":"64","author":"Packer","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0020","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM198709243171304","article-title":"Prevention and reversal of nitrate tolerance in patients with congestive heart failure","volume":"317","author":"Packer","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM198201143060201","article-title":"Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure","volume":"306","author":"Packer","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0022","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","article-title":"and the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure","volume":"325","author":"Packer","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0023","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.CIR.68.4.803","article-title":"Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure","volume":"68","author":"Packer","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0024","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0002-9149(86)90212-2","article-title":"Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy","volume":"57","author":"Packer","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0025","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.CIR.74.4.766","article-title":"Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system","volume":"74","author":"Packer","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0026","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-106-3-346","article-title":"Functional renal insufficiency during long-term therapy with captopril or enalapril for severe chronic heart failure","volume":"106","author":"Packer","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0027","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0028","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/hrt.44.2.117","article-title":"Beneficial effects of long-term beta-blockade in congestive cardiomyopathy","volume":"44","author":"Swedberg","year":"1980","journal-title":"Br Heart J"},{"issue":"Suppl IV","key":"10.1016\/j.cardfail.2023.03.028_bib0029","first-page":"80","article-title":"Role of neurohormonal mechanisms in determining the survival of patients with severe chronic heart failure","volume":"75","author":"Packer","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0735-1097(92)90167-L","article-title":"The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure","volume":"20","author":"Packer","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0031","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0735-1097(83)80316-7","article-title":"A placebo-controlled trial of captopril in refractory chronic congestive heart failure","volume":"2","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0032","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.92.6.1499","article-title":"Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in severe chronic heart failure","volume":"92","author":"Krum","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0033","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"for the US Carvedilol Hart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0034","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0036","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0037","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1161\/hc4701.099578","article-title":"Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure","volume":"104","author":"Reiken","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0038","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/sj.emboj.7600228","article-title":"Assembly of a Ca2+-dependent BK channel signaling complex by binding to beta2 adrenergic receptor","volume":"23","author":"Liu","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejheart.2007.11.006","article-title":"Chronotropic incompetence, beta-blockers, and functional capacity in advanced congestive heart failure: time to pace?","volume":"10","author":"Jorde","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-5922.2009.00072.x","article-title":"Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy","volume":"27","author":"Mignatti","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0041","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0735-1097(94)00417-O","article-title":"Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure","volume":"25","author":"Krum","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199307013290101","article-title":"Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study","volume":"329","author":"Packer","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0043","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-8703(87)90021-4","article-title":"Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure","volume":"113","author":"Kessler","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0044","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0735-1097(93)90816-J","article-title":"and the Principal Investigators of the REFLECT Study. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure","volume":"22","author":"Packer","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jchf.2017.03.003","article-title":"Long-term effects of flosequinan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the PROFILE trial after 24 years","volume":"5","author":"Packer","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0046","first-page":"1023","article-title":"for the Prospective Randomized Amlodipine Survival Evaluation Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure","volume":"336","author":"Packer","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0047","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jchf.2013.04.004","article-title":"PRAISE-2 Study Group. Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0048","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0049","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jchf.2017.02.021","article-title":"ENABLE Investigators and Committees. Long-term effect of endothelin receptor antagonism with bosentan on the morbidity and mortality of patients with severe chronic heart failure: primary results of the enable trials","volume":"5","author":"Packer","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0050","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0002-9149(99)80783-8","article-title":"Role of endothelin in the exercise intolerance of chronic heart failure","volume":"75","author":"Krum","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0051","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0002-9149(97)00920-X","article-title":"Effect of endothelin-1 on exercise-induced vasodilation in normal subjects and in patients with heart failure","volume":"81","author":"Krum","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0052","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurjhf\/hfq212","volume":"13","author":"Krum","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0053","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0054","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0055","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1161\/01.CIR.94.12.3184","article-title":"Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure","volume":"94","author":"Marcus","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0056","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1345\/aph.1G171","article-title":"Reliability of nesiritide infusion via non-primed tubing and heparin-coated catheters","volume":"39","author":"Onat","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0057","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0058","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0059","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9149(91)90101-P","article-title":"Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure","volume":"67","author":"Neuberg","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0060","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.CIR.0000030935.89559.04","article-title":"Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure","volume":"106","author":"Jorde","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0061","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.101.8.844","article-title":"Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure","volume":"101","author":"Jorde","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0062","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0063","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.0000029801.86489.50","article-title":"Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0064","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0735-1097(96)00204-5","article-title":"Exercise-induced vasodilation in forearm circulation of normal subjects and patients with congestive heart failure: role of endothelium-derived nitric oxide","volume":"28","author":"Katz","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0066","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.CIR.99.16.2113","article-title":"Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure","volume":"99","author":"Katz","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0067","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0735-1097(00)00790-7","article-title":"Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure","volume":"36","author":"Katz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0068","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0033-0620(05)80018-0","article-title":"Pulmonary factors limiting exercise capacity in patients with heart failure","volume":"37","author":"Mancini","year":"1995","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0069","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0735-1097(02)02342-2","article-title":"Selective low-level leg muscle training alleviates dyspnea in patients with heart failure","volume":"40","author":"Beniaminovitz","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.CIR.0000044914.42696.6A","article-title":"Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure","volume":"107","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0071","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0072","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1067\/mhj.2002.123144","article-title":"Prospective Randomized Amlodipine Survival Evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure","volume":"144","author":"Neuberg","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0073","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","article-title":"Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research","volume":"69","author":"Costanzo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0074","first-page":"H186","article-title":"Characterizing ventricular mechanics and energetics following repeated coronary microembolization","volume":"272","author":"Todaka","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/jmcc.1996.0266","article-title":"Coronary endothelial dysfunction precedes heart failure and reduction of coronary reserve in awake dogs","volume":"29","author":"Knecht","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0076","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0077","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.CIR.0000053947.82595.03","article-title":"Heart failure with a normal ejection fraction: is it really a disorder of diastolic function?","volume":"107","author":"Burkhoff","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0078","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cardfail.2004.10.006","article-title":"Left heart failure with a normal ejection fraction: identification of different pathophysiologic mechanisms","volume":"11","author":"Maurer","year":"2005","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0079","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jacc.2006.10.061","article-title":"Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study","volume":"49","author":"Maurer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCULATIONAHA.122.059280","article-title":"Characteristics of heart failure with preserved ejection fraction across the range of left ventricular ejection fraction","volume":"146","author":"Rosch","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0081","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/eurheartj\/ehab798","article-title":"Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction","volume":"43","author":"Butler","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0082","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0735-1097(02)01944-7","article-title":"Myocardial contraction fraction: a volumetric index of myocardial shortening by freehand three-dimensional echocardiography","volume":"40","author":"King","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0083","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1067\/mje.2002.126418","article-title":"Noncompressibility of myocardium during systole with freehand three-dimensional echocardiography","volume":"15","author":"King","year":"2002","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0084","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacc.2017.09.1157","article-title":"Myocardial contraction fraction: a volumetric measure of myocardial shortening analogous to strain","volume":"71","author":"Matthews","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0085","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jcmg.2019.12.021","article-title":"How should physicians assess myocardial contraction? Redefining heart failure with a preserved ejection fraction","volume":"13","author":"Maurer","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0086","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0087","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-5223(05)80030-3","article-title":"Use of explanted human hearts as a model for the study of cardiac pathophysiologic conditions","volume":"110","author":"Slater","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0088","doi-asserted-by":"crossref","first-page":"H1203","DOI":"10.1152\/ajpheart.00681.2004","article-title":"Role of impaired myocardial relaxation in the production of elevated left ventricular filling pressure","volume":"288","author":"Hay","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0089","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0022-5223(97)70296-4","article-title":"Systolic ventricular interaction in normal and diseased explanted human hearts","volume":"113","author":"Slater","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0090","first-page":"H2869","article-title":"Left-to-right systolic and diastolic ventricular interactions are dependent on right ventricular volume","volume":"272","author":"Dickstein","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0091","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/01.CIR.94.4.683","article-title":"Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels","volume":"94","author":"Holubarsch","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0092","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/01.CIR.99.16.2177","article-title":"Hemodynamic effects of direct biventricular compression studied in isovolumic and ejecting isolated canine hearts","volume":"99","author":"Artrip","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0093","first-page":"H1382","article-title":"Impact of exercise training on ventricular properties in a canine model of congestive heart failure","volume":"272","author":"Todaka","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0094","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1161\/01.CIR.96.8.2683","article-title":"Physical training alters the pathogenesis of pacing-induced heart failure through endothelium-mediated mechanisms in awake dogs","volume":"96","author":"Wang","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1009851107189","article-title":"Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo","volume":"6","author":"Burkhoff","year":"2001","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0096","doi-asserted-by":"crossref","first-page":"H1119","DOI":"10.1152\/ajpheart.00378.2002","article-title":"Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart","volume":"284","author":"Mohri","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0097","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ehj.2004.02.027","article-title":"Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure","volume":"25","author":"Stix","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0098","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0099","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-3565(24)29486-6","article-title":"Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure","volume":"298","author":"Suehiro","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0100","first-page":"249","article-title":"Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University","author":"Edwards","year":"1999","journal-title":"Clin Transpl"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0101","first-page":"468","article-title":"Serial assessment of exercise capacity after heart transplantation","volume":"14","author":"Mandak","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0102","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","article-title":"Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation","volume":"95","author":"Aaronson","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0103","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0735-1097(98)00697-4","article-title":"Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time","volume":"33","author":"Aaronson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0104","first-page":"1156","article-title":"Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy","volume":"14","author":"Fisher","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM200003023420902","article-title":"Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody","volume":"342","author":"Beniaminovitz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplantation vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0107","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0108","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00001573-200403000-00019","article-title":"Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment","volume":"19","author":"Pinney","year":"2004","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0109","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.healun.2003.09.036","article-title":"Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies","volume":"24","author":"Pinney","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0110","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/01.TP.0000160814.49893.FA","article-title":"Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy","volume":"79","author":"McKay","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0111","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/01.tp.0000255567.80203.bd","article-title":"Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure","volume":"83","author":"Maurer","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0112","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jacc.2003.12.012","article-title":"Heart transplantation: the increasing challenges of evidence-based decision-making","volume":"43","author":"Deng","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0113","first-page":"II87","article-title":"Artificial circulatory support with textured interior surfaces. A counterintuitive approach to minimizing thromboembolism","volume":"90","author":"Rose","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0114","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/0003-4975(94)91946-1","article-title":"Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation","volume":"58","author":"Levin","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1053-2498(01)00392-8","article-title":"Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism and increased exercise capacity","volume":"21","author":"Maybaum","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0116","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa067758","article-title":"Use of a continuous-flow device in patients awaiting heart transplantation","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0117","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1161\/01.CIR.91.11.2717","article-title":"Reversal of ventricular remodelling in patients with chronic heart failure by prolonged mechanical unloading","volume":"91","author":"Levin","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0118","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/hc3101.093903","article-title":"Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling","volume":"104","author":"Barbone","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0119","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jacc.2004.11.042","article-title":"Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties","volume":"45","author":"Klotz","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0120","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1161\/01.CIR.102.22.2713","article-title":"Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure","volume":"102","author":"Heerdt","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0121","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1161\/01.CIR.98.22.2383","article-title":"Low incidence of myocardial recovery after left .ventricular assist device implantation in patients with chronic heart failure","volume":"98","author":"Mancini","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.healun.2005.08.001","article-title":"Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery","volume":"25","author":"Xydas","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0123","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0022-5223(98)70136-9","article-title":"Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure","volume":"116","author":"Lee","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0124","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.104.515106","article-title":"Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness","volume":"112","author":"Klotz","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0125","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0003-4975(99)00042-9","article-title":"The REMATCH trial: rationale, design, and endpoints. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure","volume":"67","author":"Rose","year":"1999","journal-title":"Ann Thor Surg"},{"key":"10.1016\/j.cardfail.2023.03.028_bib0126","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423001434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423001434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:49:51Z","timestamp":1761029391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423001434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":126,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1071916423001434"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.028","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The First Dedicated Comprehensive Heart Failure Program in the United States: The Division of Circulatory Physiology at Columbia Presbyterian (1992\u20132004)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}